rs144634857

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001039141.3(TRIOBP):​c.391G>A​(p.Gly131Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0051 in 1,613,934 control chromosomes in the GnomAD database, including 43 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0046 ( 5 hom., cov: 32)
Exomes 𝑓: 0.0052 ( 38 hom. )

Consequence

TRIOBP
NM_001039141.3 missense

Scores

18

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: -0.333
Variant links:
Genes affected
TRIOBP (HGNC:17009): (TRIO and F-actin binding protein) This gene encodes a protein with an N-terminal pleckstrin homology domain and a C-terminal coiled-coil region. The protein interacts with trio, which is involved with neural tissue development and controlling actin cytoskeleton organization, cell motility and cell growth. The protein also associates with F-actin and stabilizes F-actin structures. Mutations in this gene have been associated with a form of autosomal recessive nonsyndromic deafness. Multiple alternatively spliced transcript variants that would encode different isoforms have been found for this gene, however some transcripts may be subject to nonsense-mediated decay (NMD). [provided by RefSeq, Nov 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0030972362).
BP6
Variant 22-37713346-G-A is Benign according to our data. Variant chr22-37713346-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 43850.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-37713346-G-A is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population amr. gnomad4 allele frequency = 0.00456 (694/152242) while in subpopulation AMR AF= 0.00707 (108/15270). AF 95% confidence interval is 0.00599. There are 5 homozygotes in gnomad4. There are 337 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 5 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
TRIOBPNM_001039141.3 linkuse as main transcriptc.391G>A p.Gly131Ser missense_variant 5/24 ENST00000644935.1 NP_001034230.1 Q9H2D6-1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
TRIOBPENST00000644935.1 linkuse as main transcriptc.391G>A p.Gly131Ser missense_variant 5/24 NM_001039141.3 ENSP00000496394.1 Q9H2D6-1
ENSG00000100101ENST00000455236.4 linkuse as main transcriptn.*727G>A non_coding_transcript_exon_variant 11/135 ENSP00000477208.1 V9GYY5
ENSG00000100101ENST00000455236.4 linkuse as main transcriptn.*727G>A 3_prime_UTR_variant 11/135 ENSP00000477208.1 V9GYY5

Frequencies

GnomAD3 genomes
AF:
0.00456
AC:
693
AN:
152124
Hom.:
5
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000917
Gnomad AMI
AF:
0.0548
Gnomad AMR
AF:
0.00708
Gnomad ASJ
AF:
0.0254
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00290
Gnomad FIN
AF:
0.0000943
Gnomad MID
AF:
0.0127
Gnomad NFE
AF:
0.00553
Gnomad OTH
AF:
0.00622
GnomAD3 exomes
AF:
0.00502
AC:
1252
AN:
249182
Hom.:
9
AF XY:
0.00517
AC XY:
699
AN XY:
135216
show subpopulations
Gnomad AFR exome
AF:
0.000775
Gnomad AMR exome
AF:
0.00336
Gnomad ASJ exome
AF:
0.0294
Gnomad EAS exome
AF:
0.0000556
Gnomad SAS exome
AF:
0.00219
Gnomad FIN exome
AF:
0.000233
Gnomad NFE exome
AF:
0.00632
Gnomad OTH exome
AF:
0.00677
GnomAD4 exome
AF:
0.00516
AC:
7543
AN:
1461692
Hom.:
38
Cov.:
32
AF XY:
0.00525
AC XY:
3821
AN XY:
727148
show subpopulations
Gnomad4 AFR exome
AF:
0.00146
Gnomad4 AMR exome
AF:
0.00344
Gnomad4 ASJ exome
AF:
0.0277
Gnomad4 EAS exome
AF:
0.0000504
Gnomad4 SAS exome
AF:
0.00245
Gnomad4 FIN exome
AF:
0.000338
Gnomad4 NFE exome
AF:
0.00526
Gnomad4 OTH exome
AF:
0.00614
GnomAD4 genome
AF:
0.00456
AC:
694
AN:
152242
Hom.:
5
Cov.:
32
AF XY:
0.00453
AC XY:
337
AN XY:
74436
show subpopulations
Gnomad4 AFR
AF:
0.000914
Gnomad4 AMR
AF:
0.00707
Gnomad4 ASJ
AF:
0.0254
Gnomad4 EAS
AF:
0.000193
Gnomad4 SAS
AF:
0.00311
Gnomad4 FIN
AF:
0.0000943
Gnomad4 NFE
AF:
0.00553
Gnomad4 OTH
AF:
0.00616
Alfa
AF:
0.00698
Hom.:
8
Bravo
AF:
0.00499
TwinsUK
AF:
0.00243
AC:
9
ALSPAC
AF:
0.00311
AC:
12
ESP6500AA
AF:
0.000939
AC:
4
ESP6500EA
AF:
0.00693
AC:
59
ExAC
AF:
0.00465
AC:
563
Asia WGS
AF:
0.000577
AC:
2
AN:
3478
EpiCase
AF:
0.00692
EpiControl
AF:
0.00800

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:5
Likely benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Benign, criteria provided, single submitterclinical testingGeneDxJun 20, 2019- -
Likely benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenJun 01, 2024TRIOBP: BP4, BS2 -
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 15, 2024- -
Benign, criteria provided, single submitterclinical testingAthena DiagnosticsJul 31, 2018- -
not specified Benign:3
Likely benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact SciencesMar 01, 2016- -
Benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineApr 30, 2012Gly131Ser in Exon 05 of TRIOBP: This variant is not expected to have clinical si gnificance because it has been identified in 0.7% (47/6930) of European American chromosomes from a broad population by the NHLBI Exome Sequencing Project (http ://evs.gs.washington.edu/EVS; dbSNP rs144634857). -
Likely benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Mar 31, 2015- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.083
BayesDel_addAF
Benign
-0.66
T
BayesDel_noAF
Benign
-0.72
CADD
Benign
1.3
DANN
Benign
0.88
DEOGEN2
Benign
0.011
T;T
Eigen
Benign
-1.3
Eigen_PC
Benign
-1.4
FATHMM_MKL
Benign
0.0090
N
LIST_S2
Benign
0.32
.;T
MetaRNN
Benign
0.0031
T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.34
N;N
PrimateAI
Benign
0.24
T
PROVEAN
Benign
0.21
N;.
REVEL
Benign
0.052
Sift
Benign
0.42
T;.
Sift4G
Benign
0.74
T;.
Polyphen
0.066
B;B
Vest4
0.14
MVP
0.14
MPC
0.12
ClinPred
0.00037
T
GERP RS
-4.6
Varity_R
0.014
gMVP
0.064

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs144634857; hg19: chr22-38109353; API